# Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia

> **NCT00797277** · PHASE3 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 67 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Agitation

## Interventions

- **DRUG:** IM olanzapine
- **DRUG:** IM haloperidol plus lorazepam

## Key facts

- **NCT ID:** NCT00797277
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2014-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00797277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00797277, "Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00797277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*